PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
57.89
ESG score 80-90% of EXEL's 64.74. Walter Schloss would scrutinize governance quality and regulatory exposure.
56.89
Environmental score 90-95% of EXEL's 62.70. Bill Ackman would demand clear environmental improvement catalysts.
57.56
Social score 80-90% of EXEL's 66.33. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
59.23
Governance score 90-95% of EXEL's 65.20. Bill Ackman would demand clear governance improvement catalysts.